Valeant: Is Teva’s Generic Uceris Finally Here?
In Q4 2017 a Delaware court ruled in favor of Teva (TEVA) in its challenge of patents covering Valeant's (VRX) Uceris (budesonide ER) tablets:
Teva...
Endo: Takeda Deal For Generic Colcrys Is Bullish For 2 Reasons
Things are starting to look up for Endo International (ENDP). Last month Citigroup (C) upgraded the company to "buy" and highlighted Endo's "next big...
Trump And The GE: How John McLaughlin Foresaw Obama’s 2008 Presidential Victory
Trump And The Global Economy is a quarterly speaker series that gathers economists, politicians, economists, athletes, and entrepreneurs to discuss the impact of President...
Trump Thinks He Saved U.S. From War With North Korea
President Trump is what the Shock Exchange would describe as "mercurial." When President Obama was in office Trump chastised him for even thinking about...
Talk To Ebro On Rap; Attend Trump And The GE On Trump
President Trump is arguably the most-polarizing figure ever in the White House; he seems to revel in that distinction. He call NFL players "sons...
Deandre Hopkins Invited To Trump And The GE August 8th
The social unrest the U.S. is experiencing was predicted by Ralph Baker's Shock Exchange: How Inner-City Kids From Brooklyn Predicted the Great Recession and...
Draymond Green, Warriors Skip White House Visit
The Golden State Warriors have dominated the NBA over the past few years, winning three of the previous four NBA titles. They went 73-9...
Did Judge Harvey Bartle Seal Allergan’s Fate?
When it comes to protecting its drug patents Allergan's (AGN) management team appears to be smarter than the average bear. The company has thwarted...
Will AbbVie’s Legal Woes Metastasize?
I began following AbbVie (ABBV) closely during its HCV wars with Gilead (GILD) a few years ago. Gilead won the battle; Solvaldi and Harvoni...
Celgene Is 30% Overvalued
Big pharma is on the ropes right now. Issues range from failures within their drug pipelines to high debt levels to being exposed for...
